A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 3202-3208

  Zhang, Tao ^a   Zhang, Feng ^b   Han, Yong ^a   Gu, Zhongping ^a   Zhou, Yong'an ^a   Cheng, Qingshu ^a   Zhu, Yifang ^a   Zhang, Chuanshan ^b   Wang, Yunjie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal adenocarcinoma; Esophageal metaplasia; Mixed reflux; Surgical model

Indexed keywords

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; ESOPHAGOJEJUNOSTOMY; ESOPHAGUS ANASTOMOSIS; ESOPHAGUS DISEASE; ESOPHAGUS INJURY; GASTROINTESTINAL REFLUX; GASTROJEJUNOSTOMY; INFLAMMATION; MALE; METAPLASIA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RAT; STOMACH ACID;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DUODENOSTOMY; DUODENUM; ESOPHAGEAL NEOPLASMS; ESOPHAGOSTOMY; ESOPHAGUS; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; JEJUNOSTOMY; MALE; METAPLASIA; MODELS, ANATOMIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34848876065     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9774-8     Document Type: Article

References (37)

1. Stein HJ, Barlow AP, DeMeester TR, Hinder RA (1992) Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 216:35-43
2. Ho KY, Kang JY (1999) Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere. Am J Gastroenterol 94:1186-1191
3. Holloway RH, Penagini R, Schoeman MN, Dent J (1999) Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease. Am J Gastroenterol 94:799-803
4. Cameron AJ (1997) Barrett's esophagus: does the incidence of adenocarcinoma matter? Am J Gastroenterol 92:193-194
5. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M (1997) Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 92:37-41
6. Kim R, Weissfeld JL, Reynolds JC, Kuller LH (1997) Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369-377
7. Altorki NK, Oliveria S, Schrump DS (1997) Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 13:270-280
8. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289
9. Devesa SS, Blot WJ, Fraumeni JF (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053
10. Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N (1999) Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 94:86-91
11. Vizcaino AP, Moreno V, Lambert R, Parkin DM (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99:860-868
12. Moon MR, Schulte WJ, Haasler GB, Condon RE (1992) Transhiatal and transthoracic esophagectomy for adenocarcinoma of the esophagus. Arch Surg 127:951-955
13. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW (1992) Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 33:1454-1458
14. Lerut T, Coosemans W, Van Raemdonck D, Dillemans B, De Leyn P, Marnette JM, Geboes K (1994) Surgical treatment of Barrett's carcinoma: correlations between morphologic findings and prognosis. J. Thorac Cardiovasc Surg 107:1059-1066
15. Clark GW, Roy MK, Corcoran BA, Carey PD (1996) Carcinoma of the esophagus: the time for a multidisciplinary approach? Surg Oncol 5:149-164
16. Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2:260-268
17. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, Hattori T (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67:269-274
18. Attwood SEA, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surg 111:503-510
19. Ireland AP, Peters JH, Smyrk TC, DeMeester TR, Clark GW, Mirvish SS, Adrian TE (1996) Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 224:358-371
20. Mirvish SS (1997) Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett 117:161-174
21. Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18:2265-2270
22. Nishijima K, Miwa K, Miyashita T, Kinami S, Ninomiya I, Fushida S, Fujimura T, Hattori T (2004) Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240:57-67
23. Su Y, Chen X, Klein M, Fang M, Wang S, Yang CS, Goyal RK (2004) Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest 84:753-765
24. Champion G, Richter J, Vaezi M, Singh S, Alexander R (1994) Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterol 107:747-754
25. Fiorucci S, Distrutti E, Di Matteo F, Brunori P, Santucci L, Mallozzi E, Bigazzi U, Morelli A (1995) Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol 90:270-276
26. Nehra D, Howell P, Williams CP, Pye JK, Beynon J (1999) Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44:598-602
27. Marshall RE, Anggiansah A, Owen WA, Owen WJ (2000) Investigation of gastro-oesophageal reflux in patients with an intact stomach: is oesophageal bilirubin monitoring a useful addition to pH monitoring? Scand J Gastroenterol 35:904-909
28. Vaezi MF, Richter JE (1996) Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111:1192-1199
29. Vaezi MF, Richter JE (1995) Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 117:699-704
30. Cuomo R, Koek G, Sifrim D, Janssens J, Tack J (2000) Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 45:2463-2469
31. Menges M, Muller M, Zeitz M (2001) Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 96:331-337
32. Goldstein SR, Yang GY, Chen X, Curtis SK, Yang CS (1998) Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19:1445-1449
33. Fein M, Fuchs KH, DeMeester TR, Peters JH, Wittmann D, Weig M (2000) Evaluation of the intestinal microflora in the rat model for esophageal adenocarcinoma. Dis Esophagus 13:39-43
34. Bulay O, Mirvish SS (1979) Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine. Cancer Res 39:3644-3648
35. Harmon JW, Johnson LF, Maydonovitch CL (1981) Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 26:65-72
36. Kivilaakso E, Fromm D, Silen W (1980) Effect of bile salts and related compounds on isolated esophageal mucosa. Surg 87:280-285
37. Stein HJ, Kauer WKH, Feussner H, Siewert JR (1999) Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 46:66-73